Medications for Hyperlipoproteinemia Type IIa, Elevated LDL

Other names: Fredrickson Type IIa Hyperlipoproteinemia; Hyperlipoproteinemia, Fredrickson Type IIa

Hyperlipoproteinemia Type IIa is characterized by elevated LDL but normal triglycerides and is due to a deficiency of the LDL receptor, a defect of the receptor or a modified LDL-apolipoprotein B-100, caused by mutation in the LDL receptor (LDLR) gene on chromosome 19p.

Drugs used to treat Hyperlipoproteinemia Type IIa, Elevated LDL

Name Drug Class Updated
Cholestyramine Bile acid sequestrants 16-Aug-2023
Fluvastatin Statins 17-Aug-2023
Questran packets Bile acid sequestrants 15-Aug-2023
Questran light Bile acid sequestrants 15-Aug-2023
Prevalite packets Bile acid sequestrants 15-Aug-2023
Fenofibric acid/fenofibrate (monograph) Drugs 14-Aug-2023
Colestipol Bile acid sequestrants 14-Aug-2023
Colesevelam Bile acid sequestrants 14-Aug-2023
Pravastatin Statins 11-Aug-2023
Lovastatin Statins 11-Aug-2023
Altoprev Statins 07-Aug-2023
Altocor Statins 07-Aug-2023
Cholestyramine light Bile acid sequestrants 05-Aug-2023
Antara Fibric acid derivatives 05-Aug-2023
Lipofen Fibric acid derivatives 05-Aug-2023
Simcor Antihyperlipidemic combinations 05-Aug-2023
Lescol xl Statins 05-Aug-2023
Lescol Statins 05-Aug-2023
Triglide Fibric acid derivatives 14-Jul-2023
Tricor Fibric acid derivatives 14-Jul-2023
Prevalite Bile acid sequestrants 14-Jul-2023
Fenoglide Fibric acid derivatives 13-Jul-2023
Colestid flavored Bile acid sequestrants 13-Jul-2023
Colestid Bile acid sequestrants 13-Jul-2023
Atorvaliq Drugs 12-Jul-2023
Welchol Bile acid sequestrants 12-Jul-2023
Questran Bile acid sequestrants 11-Jul-2023
Fenofibrate Fibric acid derivatives 10-Jul-2023
Share this Article
Latest News
Related Drugs